REIT - Specialty
Compare Stocks
4 / 10Stock Comparison
CXW vs CTAS vs ABM vs G
Revenue, margins, valuation, and 5-year total return — side by side.
Specialty Business Services
Specialty Business Services
Information Technology Services
CXW vs CTAS vs ABM vs G — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | REIT - Specialty | Specialty Business Services | Specialty Business Services | Information Technology Services |
| Market Cap | $2.16B | $68.52B | $2.39B | $5.85B |
| Revenue (TTM) | $2.34B | $10.79B | $8.87B | $5.16B |
| Net Income (TTM) | $129M | $1.90B | $158M | $570M |
| Gross Margin | 23.6% | 50.2% | 11.5% | 36.3% |
| Operating Margin | 14.7% | 23.0% | 3.7% | 14.9% |
| Forward P/E | 14.4x | 34.8x | 10.3x | 8.6x |
| Total Debt | $1.22B | $2.65B | $1.69B | $1.76B |
| Cash & Equiv. | $112M | $264M | $104M | $854M |
CXW vs CTAS vs ABM vs G — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| CoreCivic, Inc. (CXW) | 100 | 181.3 | +81.3% |
| Cintas Corporation (CTAS) | 100 | 274.3 | +174.3% |
| ABM Industries Inco… (ABM) | 100 | 132.6 | +32.6% |
| Genpact Limited (G) | 100 | 95.9 | -4.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CXW vs CTAS vs ABM vs G
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CXW is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 12.7%, EPS growth 74.2%, 3Y rev CAGR 6.2%
- 12.7% FFO/revenue growth vs ABM's 4.6%
- -3.5% vs G's -29.0%
CTAS carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.
- 6.9% 10Y total return vs ABM's 48.7%
- Lower volatility, beta 0.51, Low D/E 56.7%, current ratio 2.09x
- Beta 0.51, yield 0.9%, current ratio 2.09x
- 17.6% margin vs ABM's 1.8%
ABM is the clearest fit if your priority is income & stability and valuation efficiency.
- Dividend streak 36 yrs, beta 0.72, yield 2.6%
- PEG 0.04 vs CTAS's 2.08
- 2.6% yield, 36-year raise streak, vs CTAS's 0.9%, (1 stock pays no dividend)
G is the clearest fit if your priority is value.
- Lower P/E (8.6x vs 34.8x), PEG 0.58 vs 2.08
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.7% FFO/revenue growth vs ABM's 4.6% | |
| Value | Lower P/E (8.6x vs 34.8x), PEG 0.58 vs 2.08 | |
| Quality / Margins | 17.6% margin vs ABM's 1.8% | |
| Stability / Safety | Beta 0.51 vs ABM's 0.72, lower leverage | |
| Dividends | 2.6% yield, 36-year raise streak, vs CTAS's 0.9%, (1 stock pays no dividend) | |
| Momentum (1Y) | -3.5% vs G's -29.0% | |
| Efficiency (ROA) | 18.7% ROA vs ABM's 3.0%, ROIC 25.8% vs 7.5% |
CXW vs CTAS vs ABM vs G — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CXW vs CTAS vs ABM vs G — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CTAS leads in 2 of 6 categories
CXW leads 1 • ABM leads 1 • G leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CTAS leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CTAS is the larger business by revenue, generating $10.8B annually — 4.6x CXW's $2.3B. CTAS is the more profitable business, keeping 17.6% of every revenue dollar as net income compared to ABM's 1.8%. On growth, CXW holds the edge at +25.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $2.3B | $10.8B | $8.9B | $5.2B |
| EBITDAEarnings before interest/tax | $475M | $2.9B | $431M | $819M |
| Net IncomeAfter-tax profit | $129M | $1.9B | $158M | $570M |
| Free Cash FlowCash after capex | $49M | $1.8B | $327M | $666M |
| Gross MarginGross profit ÷ Revenue | +23.6% | +50.2% | +11.5% | +36.3% |
| Operating MarginEBIT ÷ Revenue | +14.7% | +23.0% | +3.7% | +14.9% |
| Net MarginNet income ÷ Revenue | +5.5% | +17.6% | +1.8% | +11.0% |
| FCF MarginFCF ÷ Revenue | +2.1% | +16.5% | +3.7% | +12.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +25.8% | +9.3% | +6.1% | +6.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +56.5% | +11.0% | -7.2% | +17.8% |
Valuation Metrics
Evenly matched — ABM and G each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 11.0x trailing earnings, G trades at a 71% valuation discount to CTAS's 38.6x P/E. Adjusting for growth (PEG ratio), ABM offers better value at 0.05x vs CTAS's 2.31x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $2.2B | $68.5B | $2.4B | $5.9B |
| Enterprise ValueMkt cap + debt − cash | $3.3B | $70.9B | $4.0B | $6.8B |
| Trailing P/EPrice ÷ TTM EPS | 20.19x | 38.65x | 15.74x | 11.02x |
| Forward P/EPrice ÷ next-FY EPS est. | 14.44x | 34.75x | 10.30x | 8.58x |
| PEG RatioP/E ÷ EPS growth rate | 1.06x | 2.31x | 0.05x | 0.74x |
| EV / EBITDAEnterprise value multiple | 6.83x | 24.85x | 9.23x | 7.91x |
| Price / SalesMarket cap ÷ Revenue | 0.98x | 6.63x | 0.27x | 1.15x |
| Price / BookPrice ÷ Book value/share | 1.67x | 14.89x | 1.43x | 2.39x |
| Price / FCFMarket cap ÷ FCF | 39.96x | 39.00x | 15.40x | 7.97x |
Profitability & Efficiency
CTAS leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
CTAS delivers a 42.6% return on equity — every $100 of shareholder capital generates $43 in annual profit, vs $9 for ABM. CTAS carries lower financial leverage with a 0.57x debt-to-equity ratio, signaling a more conservative balance sheet compared to ABM's 0.95x. On the Piotroski fundamental quality scale (0–9), CTAS scores 9/9 vs G's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +9.0% | +42.6% | +8.8% | +22.4% |
| ROA (TTM)Return on assets | +4.0% | +18.7% | +3.0% | +10.3% |
| ROICReturn on invested capital | +10.7% | +25.8% | +7.5% | +17.2% |
| ROCEReturn on capital employed | +12.6% | +29.8% | +8.2% | +18.4% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 9 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.87x | 0.57x | 0.95x | 0.69x |
| Net DebtTotal debt minus cash | $1.1B | $2.4B | $1.6B | $911M |
| Cash & Equiv.Liquid assets | $112M | $264M | $104M | $854M |
| Total DebtShort + long-term debt | $1.2B | $2.7B | $1.7B | $1.8B |
| Interest CoverageEBIT ÷ Interest expense | 3.53x | 24.61x | 3.25x | 16.55x |
Total Returns (Dividends Reinvested)
CXW leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CXW five years ago would be worth $26,794 today (with dividends reinvested), compared to $7,921 for G. Over the past 12 months, CXW leads with a -3.5% total return vs G's -29.0%. The 3-year compound annual growth rate (CAGR) favors CXW at 33.0% vs G's -2.5% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +14.7% | -7.8% | -3.1% | -24.5% |
| 1-Year ReturnPast 12 months | -3.5% | -20.1% | -16.0% | -29.0% |
| 3-Year ReturnCumulative with dividends | +135.0% | +51.7% | +3.4% | -7.4% |
| 5-Year ReturnCumulative with dividends | +167.9% | +95.8% | -14.1% | -20.8% |
| 10-Year ReturnCumulative with dividends | -13.4% | +685.0% | +48.7% | +42.5% |
| CAGR (3Y)Annualised 3-year return | +33.0% | +14.9% | +1.1% | -2.5% |
Risk & Volatility
Evenly matched — CXW and CTAS each lead in 1 of 2 comparable metrics.
Risk & Volatility
CTAS is the less volatile stock with a 0.51 beta — it tends to amplify market swings less than ABM's 0.72 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CXW currently trades 92.7% from its 52-week high vs G's 68.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.61x | 0.51x | 0.72x | 0.67x |
| 52-Week HighHighest price in past year | $23.54 | $229.24 | $52.94 | $50.24 |
| 52-Week LowLowest price in past year | $15.74 | $165.46 | $36.96 | $33.12 |
| % of 52W HighCurrent price vs 52-week peak | +92.7% | +74.2% | +77.0% | +68.6% |
| RSI (14)Momentum oscillator 0–100 | 60.3 | 37.7 | 54.8 | 35.4 |
| Avg Volume (50D)Average daily shares traded | 993K | 2.2M | 512K | 2.3M |
Analyst Outlook
ABM leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CXW as "Buy", CTAS as "Hold", ABM as "Hold", G as "Hold". Consensus price targets imply 33.4% upside for G (target: $46) vs -28.9% for CXW (target: $16). For income investors, ABM offers the higher dividend yield at 2.57% vs CTAS's 0.88%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | $15.50 | $223.40 | $50.00 | $46.00 |
| # AnalystsCovering analysts | 12 | 30 | 11 | 39 |
| Dividend YieldAnnual dividend ÷ price | +0.0% | +0.9% | +2.6% | +1.9% |
| Dividend StreakConsecutive years of raises | 0 | 3 | 36 | 8 |
| Dividend / ShareAnnual DPS | $0.00 | $1.49 | $1.05 | $0.67 |
| Buyback YieldShare repurchases ÷ mkt cap | +10.6% | +1.4% | +5.1% | +4.8% |
CTAS leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CXW leads in 1 (Total Returns). 2 tied.
CXW vs CTAS vs ABM vs G: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CXW or CTAS or ABM or G a better buy right now?
For growth investors, CoreCivic, Inc.
(CXW) is the stronger pick with 12. 7% revenue growth year-over-year, versus 4. 6% for ABM Industries Incorporated (ABM). Genpact Limited (G) offers the better valuation at 11. 0x trailing P/E (8. 6x forward), making it the more compelling value choice. Analysts rate CoreCivic, Inc. (CXW) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CXW or CTAS or ABM or G?
On trailing P/E, Genpact Limited (G) is the cheapest at 11.
0x versus Cintas Corporation at 38. 6x. On forward P/E, Genpact Limited is actually cheaper at 8. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: ABM Industries Incorporated wins at 0. 04x versus Cintas Corporation's 2. 08x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CXW or CTAS or ABM or G?
Over the past 5 years, CoreCivic, Inc.
(CXW) delivered a total return of +167. 9%, compared to -20. 8% for Genpact Limited (G). Over 10 years, the gap is even starker: CTAS returned +685. 0% versus CXW's -13. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CXW or CTAS or ABM or G?
By beta (market sensitivity over 5 years), Cintas Corporation (CTAS) is the lower-risk stock at 0.
51β versus ABM Industries Incorporated's 0. 72β — meaning ABM is approximately 43% more volatile than CTAS relative to the S&P 500. On balance sheet safety, Cintas Corporation (CTAS) carries a lower debt/equity ratio of 57% versus 95% for ABM Industries Incorporated — giving it more financial flexibility in a downturn.
05Which is growing faster — CXW or CTAS or ABM or G?
By revenue growth (latest reported year), CoreCivic, Inc.
(CXW) is pulling ahead at 12. 7% versus 4. 6% for ABM Industries Incorporated (ABM). On earnings-per-share growth, the picture is similar: ABM Industries Incorporated grew EPS 102. 3% year-over-year, compared to 9. 8% for Genpact Limited. Over a 3-year CAGR, CTAS leads at 9. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CXW or CTAS or ABM or G?
Cintas Corporation (CTAS) is the more profitable company, earning 17.
5% net margin versus 1. 9% for ABM Industries Incorporated — meaning it keeps 17. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CTAS leads at 22. 8% versus 3. 7% for ABM. At the gross margin level — before operating expenses — CTAS leads at 50. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CXW or CTAS or ABM or G more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, ABM Industries Incorporated (ABM) is the more undervalued stock at a PEG of 0. 04x versus Cintas Corporation's 2. 08x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Genpact Limited (G) trades at 8. 6x forward P/E versus 34. 8x for Cintas Corporation — 26. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for G: 33. 4% to $46. 00.
08Which pays a better dividend — CXW or CTAS or ABM or G?
In this comparison, ABM (2.
6% yield), G (1. 9% yield), CTAS (0. 9% yield) pay a dividend. CXW does not pay a meaningful dividend and should not be held primarily for income.
09Is CXW or CTAS or ABM or G better for a retirement portfolio?
For long-horizon retirement investors, Cintas Corporation (CTAS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
51), 0. 9% yield, +685. 0% 10Y return). Both have compounded well over 10 years (CTAS: +685. 0%, CXW: -13. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CXW and CTAS and ABM and G?
These companies operate in different sectors (CXW (Real Estate) and CTAS (Industrials) and ABM (Industrials) and G (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CXW is a small-cap quality compounder stock; CTAS is a mid-cap quality compounder stock; ABM is a small-cap deep-value stock; G is a small-cap deep-value stock. CTAS, ABM, G pay a dividend while CXW does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.